Product Name:

Pim2-BKCD


Product Number:

ab-nk288-1

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Serine/threonine-protein kinase Pim-2

Target Alias: Pim-2h; ENSG00000102096

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK288-1

Antibody Target Type: Pan-specific

Protein UniProt: Q9P1W9

Protein SigNET: Q9P1W9

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human Pim2 sequence peptide Cat. No.: PE-01BER85

Antibody Immunogen Sequence: PGGKDREAFEAEYRLGC

Antibody Immunogen Description: Corresponds to amino acid residues P20 to G35; Just before kinase catalytic domain

Production Method: Corresponds to amino acid residues P20 to G35; Just before kinase catalytic domain

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 0.14 / 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Weak immunoreactivity of a target-sized protein by Western blotting in mouse brain.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 34-38 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No significant cross-reactivities detected in various human cancer cell lines, including A431, HEK-293, HeLa, HepG2, Jurkat and MCF7 cells, as well as in mouse brain, skeletal muscle, testes and thymus.

Scientific Background: Pim2 is a protein-serine/threonine kinase of the CAMK group and Pim family. The Pim2 protein, along with the related Pim1 and Pim3 proteins, promotes cell survival and proliferation by acting downstream of cytokine and growth factor signalling pathways. It regulates Myc transcription and stabilization by phosphorylation. It also prevents apoptosis by phosphorylating and inactivating the proapoptotic protein Bad. It induces cell survival and proliferation signals via NF-KB cascade and phosphorylation and inhibition of CDKN1A and CDKN1B. Dysregulation of Pim2 can promote cell proliferation and resistance to apoptosis and oncogenesis. The very low frequency of reported somatic mutations in this protein indicates that it may function as a tumour requiring protein (TRP) in many human tumours. Although it is considered as an oncoprotein (OP), it shows a level of bystander mutations typical of most proteins in human cancers. The active form of the protein kinase normally acts to promote tumour cell proliferation. Pim2 is linked to Mantle Cell Lymphomas (LCM), which are non-Hodgkin lymphomas in which is specifically a B-cell lymphoma is also associated the ATM (ataxia telangiectasia mutated) gene.